Description: Further DetailsTitle: Drug RepositioningCondition: NewDescription: The how's and why's of successful drug repositioning Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy. Drug Repositioning is divided into three parts: Part 1, Drug Repositioning: Business Case, Strategies, and Operational Considerations, examines the medical and commercial drivers underpinning the quest to reposition existing drugs, guiding readers through the key strategic, technical, operational, and regulatory decisions needed for successful drug repositioning programs. Part 2, Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs, sets forth computational-based strategies, tools, and databases that have been designed for repositioning studies, screening approaches, including combinations of existing drugs, and a look at the development of chemically modified analogs of approved agents. Part 3, Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry, explores current investigations for repositioning drugs to treat rare and neglected diseases, which are frequently overlooked by for-profit pharmaceutical companies due to their lack of commercial return. The book's appendix provides valuable resources for drug repositioning researchers, including information on drug repositioning and reformulation companies, databases, government resources and organizations, regulatory agencies, and drug repositioning initiatives from academia and non-profits. With this book as their guide, students and pharmaceutical researchers can learn how to use drug repositioning techniques to extend the lifespan and applications of existing drugs as well as maximize the return on investment in drug research and development.Author: Michael J. Barratt, Donald E. FrailCountry/Region of Manufacture: USEAN: 9780470878279Format: HardbackGenre: MedicineISBN: 9780470878279Item Height: 241mmItem Length: 155mmItem Weight: 884gItem Width: 32mmLanguage: EnglishPublisher: John Wiley & Sons IncRelease Date: 07/06/2012Subtitle: Bringing New Life to Shelved Assets and Existing DrugsRelease Year: 2012 Missing Information?Please contact us if any details are missing and where possible we will add the information to our listing.
Price: 194.52 USD
Location: GU14 0GT
End Time: 2024-11-17T03:48:13.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 30 Days
Refund will be given as: Money back or replacement (buyer's choice)
Return policy details:
Book Title: Drug Repositioning
Country/Region of Manufacture: US
EAN: 9780470878279
Genre: Medicine
ISBN: 9780470878279
Release Date: 07/06/2012
Release Year: 2012
Subtitle: Bringing New Life to Shelved Assets and Existing Drugs
Title: Drug Repositioning
Number of Pages: 498 Pages
Publication Name: Drug Repositioning : Bringing New Life to Shelved ASSETS and Existing Drugs
Language: English
Publisher: Wiley & Sons, Incorporated, John
Item Height: 1.3 in
Subject: Pharmacology
Publication Year: 2012
Type: Textbook
Item Weight: 48.1 Oz
Item Length: 9.5 in
Subject Area: Medical
Author: Donald E. Frail, Michael J. Barratt
Item Width: 6.5 in
Format: Hardcover
